Sign up to save your podcasts
Or
Share Stuart Anderson, "Pharmacopoeias, Drug Regulation, and Empires: Making Medicines Official in Britain's Imperial World, 1618-1968" (McGill-Queen's UP, 2024)
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Stuart Anderson, "Pharmacopoeias, Drug Regulation, and Empires: Making Medicines Official in Britain's Imperial World, 1618-1968" (McGill-Queen's UP, 2024)
The word "pharmacopoeia" has come to have many meanings, although it is commonly understood to be a book describing approved compositions and standards for drugs. In 1813 the Royal College of Physicians of London considered a proposal to develop an imperial British pharmacopoeia - at a time when separate official pharmacopoeias existed for England, Scotland, and Ireland. A unified British pharmacopoeia was published in 1864, and by 1914 it was considered suitable for the whole Empire.
Pharmacopoeias, Drug Regulation, and Empires: Making Medicines Official in Britain's Imperial World, 1618-1968 (McGill-Queen's University Press, 2024) by Dr. Stuart Anderson traces the 350-year development of officially sanctioned pharmacopoeias across the British Empire, first from local to national pharmacopoeias, and later to a standardised pharmacopoeia that would apply throughout Britain’s imperial world. The evolution of British pharmacopoeias and the professionalisation of medicine saw developments including a transition from Galenic principles to germ theory, and a shift from plant-based to chemical medicines. While other colonial powers in Europe usually imposed metropolitan pharmacopoeias across their colonies, Britain consulted with practitioners throughout its Empire. As the scope of the pharmacopoeia widened, the process of agreeing upon drug standardisation became more complex and fraught. A wide range of issues was exposed, from bioprospecting and the inclusion of indigenous medicines in pharmacopoeias, to adulteration and demands for the substitution of pharmacopoeial drugs with locally available ones.
Pharmacopoeias, Drug Regulation, and Empires uses the evolution of an imperial pharmacopoeia in Britain as a vehicle for exploring the hegemonic power of European colonial powers in the medical field, and the meaning of pharmacopoeia more broadly.
This interview was conducted by Dr. Miranda Melcher whose new book focuses on post-conflict military integration, understanding treaty negotiation and implementation in civil war contexts, with qualitative analysis of the Angolan and Mozambican civil wars.
Learn more about your ad choices. Visit megaphone.fm/adchoices
Support our show by becoming a premium member! https://newbooksnetwork.supportingcast.fm/science-technology-and-society
View all episodes
By New Books Network
3.7
3131 ratings
The word "pharmacopoeia" has come to have many meanings, although it is commonly understood to be a book describing approved compositions and standards for drugs. In 1813 the Royal College of Physicians of London considered a proposal to develop an imperial British pharmacopoeia - at a time when separate official pharmacopoeias existed for England, Scotland, and Ireland. A unified British pharmacopoeia was published in 1864, and by 1914 it was considered suitable for the whole Empire.
Pharmacopoeias, Drug Regulation, and Empires: Making Medicines Official in Britain's Imperial World, 1618-1968 (McGill-Queen's University Press, 2024) by Dr. Stuart Anderson traces the 350-year development of officially sanctioned pharmacopoeias across the British Empire, first from local to national pharmacopoeias, and later to a standardised pharmacopoeia that would apply throughout Britain’s imperial world. The evolution of British pharmacopoeias and the professionalisation of medicine saw developments including a transition from Galenic principles to germ theory, and a shift from plant-based to chemical medicines. While other colonial powers in Europe usually imposed metropolitan pharmacopoeias across their colonies, Britain consulted with practitioners throughout its Empire. As the scope of the pharmacopoeia widened, the process of agreeing upon drug standardisation became more complex and fraught. A wide range of issues was exposed, from bioprospecting and the inclusion of indigenous medicines in pharmacopoeias, to adulteration and demands for the substitution of pharmacopoeial drugs with locally available ones.
Pharmacopoeias, Drug Regulation, and Empires uses the evolution of an imperial pharmacopoeia in Britain as a vehicle for exploring the hegemonic power of European colonial powers in the medical field, and the meaning of pharmacopoeia more broadly.
This interview was conducted by Dr. Miranda Melcher whose new book focuses on post-conflict military integration, understanding treaty negotiation and implementation in civil war contexts, with qualitative analysis of the Angolan and Mozambican civil wars.
Learn more about your ad choices. Visit megaphone.fm/adchoices
Support our show by becoming a premium member! https://newbooksnetwork.supportingcast.fm/science-technology-and-society
More shows like New Books in Science, Technology, and Society
View all
The New Yorker Radio Hour
6,784 Listeners
The LRB Podcast
290 Listeners
On the Media
9,193 Listeners
The Political Scene | The New Yorker
3,987 Listeners
The Gray Area with Sean Illing
10,748 Listeners
In Our Time
5,541 Listeners
New Books in Critical Theory
146 Listeners
Jacobin Radio
1,449 Listeners
The Lawfare Podcast
6,302 Listeners
Interesting Times with Ross Douthat
7,164 Listeners
Know Your Enemy
2,047 Listeners
Tech Won't Save Us
559 Listeners
Acid Horizon
199 Listeners
Hard Fork
5,470 Listeners
The Ezra Klein Show
16,097 Listeners